1995
DOI: 10.1001/archderm.131.8.892
|View full text |Cite
|
Sign up to set email alerts
|

Granulocyte-macrophage colony-stimulating factor in the management of severe ecthyma gangrenosum related to myelodysplastic syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1996
1996
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Our patient also showed a good response to appropriate antibiotics. In a similar case study of an adult patient with myelofibrosis and persistent lesions of EG for about four weeks, granulocyte-macrophage colony stimulating factor (GM-CSF) was successfully used in the treatment regimen [ 3 ]. This indicates that supportive therapies to correct cytopenias can also be used for better outcomes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our patient also showed a good response to appropriate antibiotics. In a similar case study of an adult patient with myelofibrosis and persistent lesions of EG for about four weeks, granulocyte-macrophage colony stimulating factor (GM-CSF) was successfully used in the treatment regimen [ 3 ]. This indicates that supportive therapies to correct cytopenias can also be used for better outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…There is ample evidence that it may occur secondary to other organisms as well, even occurring in the absence of bacteremia [ 1 ]. Immunocompromised children, such as those with leukemia, are often affected by it; in adults, the condition has also been linked to myelofibrosis [ 2 - 3 ]. Myelofibrosis, a disorder of hematopoietic stem cells, seen rarely in the pediatric population, is characterized by poor proliferation of one or more: myeloid lineage markers, reactive fibrosis of the bone, and extramedullary hematopoiesis.…”
Section: Introductionmentioning
confidence: 99%